Post by Allmed Group

Under the theme “Open Your Mind” one message stood out at ERA 2026: the future of nephrology starts before kidney failure. The focus is rapidly shifting from treating advanced disease to preventing progression through earlier diagnosis, cardio-renal-metabolic care, and innovative therapies such as GLP-1 and SGLT2 inhibitors. From AI-assisted risk prediction to new cardio-renal therapies, nephrology is entering an era of earlier intervention and more personalized treatment. The field is moving toward: Predict → Prevent → Personalize The next decade in kidney care will be defined by prevention, precision, and better patient outcomes. Alongside advances in prevention and precision medicine, innovation across the kidney care continuum remains essential. At ERA 2026, Allmed introduced Vapure®, our new generation of BIOSTEAM®-sterilised PES dialyzers, designed to support high-performance dialysis therapy while meeting the highest standards of biocompatibility for patients. Which trend do you see shaping the future of kidney care? #ERA2026 Source: ERA Congress 2026 scientific sessions and clinical trial presentations.